Alpha-1 blockers and susceptibility to COVID-19 in benign prostate hyperplasia patients : an international cohort study

Alpha-1 blockers, often used to treat benign prostate hyperplasia (BPH), have been hypothesized to prevent COVID-19 complications by minimising cytokine storms release. We conducted a prevalent-user active-comparator cohort study to assess association between alpha-1 blocker use and risks of three C...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishimura, Akihiko, Xie, Junqing, Kostka, Kristin, Duarte-Salles, Talita, Bertolín, Sergio Fernández, Aragón, María, Blacketer, Clair, Shoaibi, Azza, DuVall, Scott L, Lynch, Kristine, Matheny, Michael E, Falconer, Thomas, Morales, Daniel R, Conover, Mitchell M, You, Seng Chan, Pratt, Nicole, Weaver, James, Sena, Anthony G, Schuemie, Martijn J, Reps, Jenna, Reich, Christian, Rijnbeek, Peter R, Ryan, Patrick B, Hripcsak, George, Prieto-Alhambra, Daniel, Suchard, Marc A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010772/
https://www.ncbi.nlm.nih.gov/pubmed/33791740
http://dx.doi.org/10.1101/2021.03.18.21253778

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010772/
https://www.ncbi.nlm.nih.gov/pubmed/33791740
http://dx.doi.org/10.1101/2021.03.18.21253778

Ejemplares similares